Novel Excipients Needed More Than Ever Before: Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied.

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Vol. 45; no. 3; pp. 24 - 28
Autor principal: Challener, Cynthia A.
Formato: Journal Article
Publicado: MJH Life Sciences Mar2021
Acceso en línea:Ver este registro en EBSCOhost